A Morbidity-Mortality and Remodeling Study With Valsartan

Active, not recruiting

Phase 4 Results N/A

References

Publications

  • Mochizuki S, Shimizu M, Taniguchi I, Kanae K, Yoshida S, Tajima N, Dahlof B; The JIKEI HEART Study Group. JIKEI HEART Study--a morbi-mortality and remodeling study with valsartan in Japanese patients with hypertension and cardiovascular disease. Cardiovasc Drugs Ther. 2004 Jul;18(4):305-9. Pubmed ID:15367828

Sources for Trial Information